Otsuka Novel Products GmbH
1 clinical trials · Sponsor
◉ Watch Otsuka Novel Products GmbH
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer (NCT02042885) | Otsuka Novel Products GmbH | 2014-01-01 |
Track Otsuka Novel Products GmbH automatically
Every clearance here is in the API, with alerts when new ones post.